NASDAQ:HGEN - Nasdaq - US4448632038 - Common Stock - Currency: USD
TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 1.70M | 2.51M | 3.60M | 310.00K | 0.00 | |||
Operating Expenses | 53.71M | 70.82M | 236.37M | 88.51M | 8.94M | |||
Research and Development | 38.73M | 55.21M | 213.12M | 72.71M | 2.62M | |||
Selling, General, and Administrative Expenses | 14.98M | 15.61M | 23.25M | 15.80M | 6.33M | |||
Operating Income | -52.01M | -68.30M | -232.77M | -88.20M | -8.94M | |||
Interest Income/Expense | -2.20M | -2.92M | -2.26M | -1.34M | -1.35M | |||
Other Income/Expense | 578.00K | 492.00K | -1.61M | 0.00 | 0.00 | |||
Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
Income Before Taxes | -53.63M | -70.73M | -236.65M | -89.54M | -10.29M | |||
Income Tax | N/A | N/A | N/A | N/A | N/A | |||
Net Income | -53.63M | -70.73M | -236.65M | -89.54M | -10.29M | |||
EBITDA | N/A | N/A | N/A | N/A | N/A | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.66 | -0.79 | -4.04 | -2.42 | -0.46 | |||
Non GAAP EPS | -0.65 | -0.93 | -4.10 | N/A | N/A | |||
Statistics | ||||||||
Profit Margin | -3156.80% | -2813.44% | -6582.73% | -28883.87% | N/A | |||
Operating Profit Margin | -3061.21% | -2716.95% | -6474.88% | -28451.61% | N/A |
All data in USD